029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
UBD1501膀胱癌组织芯片,附病理分级、TNM和临床分期,75例/150点
点 数150例 数75
行 数10列 数15
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:UBD1501
 
膀胱癌组织微阵列芯片,包含尿路上皮癌49例,腺癌12例,鳞状细胞癌7例,复合性癌及平滑肌肉瘤各1例,慢性膀胱炎5例,一例两点(同一病人组织在上下两行同一位置点样)
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Bla
-Bladder
 
Inflammation (*)
 
Malignant (I)
 
Malignant (II)
 
Malignant (IIIA)
 
Malignant (IIIB)
TISSUE  ARRAYS UBD1501
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
A
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
B
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
C
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
D
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
E
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
F
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
G
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
H
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
I
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
J
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1172MBladderLow-grade urothelial carcinoma (sparse)*T3N0M0IIIAMalignant4*3*2N
A2251MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
A3359FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
A4479FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*5*1.5N
A5545FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
A6672MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*5*2.5N
A7742MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3*3N
A8871MBladderLow-grade urothelial carcinoma*T2bN0M0IIMalignant4.5*3*2N
A9950MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
A101025FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant13*10*8N
A111148MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
A121273FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
A131371MBladderHigh grade urothelial carcinoma (interstitial)*T3bN0M0IIIAMalignant8*7N
A141445FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant10*7*7N
A151552MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant6*5*2N
B11672MBladderLow-grade urothelial carcinoma*T3N0M0IIIAMalignant4*3*2N
B21751MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
B31859FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
B41979FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*5*1.5N
B52045FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
B62172MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*5*2.5N
B72242MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3*3N
B82371MBladderLow-grade urothelial carcinoma*T2bN0M0IIMalignant4.5*3*2N
B92450MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
B102525FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant13*10*8N
B112648MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
B122773FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
B132871MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant8*7N
B142945FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant10*7*7N
B153052MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant6*5*2N
C13169MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant2.5*2.5*2.5N
C23235MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant*N
C33365MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*3*1N
C43470MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant6*5*3N
C53544MBladderHigh grade urothelial carcinoma (sparse)*T2N0M0IIMalignant*N
C63670MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant5*4*3N
C73742MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
C83867MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant4*3*3N
C93956MBladderHigh grade urothelial carcinoma (sparse)*T3N0M0IIIAMalignant*N
C104033MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant*N
C114165FBladderHigh grade urothelial carcinoma (sparse)*T3aN0M0IIIAMalignant4*3*2N
C124237FBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
C134345FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
C144455MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1.5N
C154570FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
D14669MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant2.5*2.5*2.5N
D24735MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant*N
D34865MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*3*1N
D44970MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant6*5*3N
D55044MBladderHigh grade urothelial carcinoma (sparse)*T2N0M0IIMalignant*N
D65170MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant5*4*3N
D75242MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
D85367MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant4*3*3N
D95456MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
D105533MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant*N
D115665FBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant4*3*2N
D125737FBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
D135845FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
D145955MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1.5N
D156070FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
E16170FBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant*N
E26278FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*5*2N
E36365MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*2*1N
E46450FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
E56582MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
E66661MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E76760FBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant*N
E86858MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E96977FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant2*1.5*1N
E107074MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
E117168MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
E127266MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E137360FBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant3*2*2N
E147467MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant7*4*3N
E157556MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
F17670FBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant*N
F27778FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*5*2N
F37865MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*2*1N
F47950FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
F58082MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
F68161MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
F78260FBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant*N
F88358MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
F98477FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant2*1.5*1N
F108574MBladderHigh grade urothelial carcinoma (sparse)*T3N0M0IIIAMalignant*N
F118668MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
F128766MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
F138860FBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant3*2*2N
F148967MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant7*4*3N
F159056MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
G19157FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant6*4*4N
G29242MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant5*5*4N
G39374FBladderHigh grade urothelial carcinoma (interstitial)*T2bN0M0IIMalignant*N
G49445MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
G59546FBladderAdenocarcinoma2T3bN2M0IIIBMalignant*N
G69660MBladderAdenocarcinoma2T2N1M0IIIAMalignant*N
G79748FBladderAdenocarcinoma with degeneration2T3N0M0IIIAMalignant10*6*3N
G89874FBladderAdenocarcinoma2T1N0M0IMalignant3*2*2N
G99957MBladderAdenocarcinoma2T1N0M0IMalignant*N
G1010076MBladderAdenocarcinoma2--3T4N0M0IIIAMalignant*N
G1110158MBladderAdenocarcinoma3T2N0M0IIMalignant4.5N
G1210265MBladderAdenocarcinoma3T4N0M0IIIAMalignant2.5*1.5*1N
G1310370MBladderAdenocarcinoma3T2bN0M0IIMalignant*N
G1410443MBladderAdenocarcinoma (sparse)3T3aN0M0IIIAMalignant10*7*6N
G1510565MBladderAdenocarcinoma (degeneration and necrosis)3T3bN0M0IIIAMalignant3*1.5N
H110657FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant6*4*4N
H210742MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant5*5*4N
H310874FBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
H410945MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
H511046FBladderAdenocarcinoma2T3bN2M0IIIBMalignant*N
H611160MBladderAdenocarcinoma2T2N1M0IIIAMalignant*N
H711248FBladderAdenocarcinoma with degeneration2T3N0M0IIIAMalignant10*6*3N
H811374FBladderAdenocarcinoma2T1N0M0IMalignant3*2*2N
H911457MBladderAdenocarcinoma2T1N0M0IMalignant*N
H1011576MBladderAdenocarcinoma (sparse)2--3T4N0M0IIIAMalignant*N
H1111658MBladderAdenocarcinoma3T2N0M0IIMalignant4.5N
H1211765MBladderAdenocarcinoma3T4N0M0IIIAMalignant2.5*1.5*1N
H1311870MBladderAdenocarcinoma3T2bN0M0IIMalignant*N
H1411943MBladderAdenocarcinoma3T3aN0M0IIIAMalignant10*7*6N
H1512065MBladderAdenocarcinoma (interstitial)3T3bN0M0IIIAMalignant3*1.5N
I112150MBladderAdenocarcinoma3T3N0M0IIIAMalignant6*5*2.5N
I212253MBladderSquamous cell carcinoma1T2N0M0IIMalignant4.5*4.5*3N
I312346MBladderSquamous cell carcinoma1T2aN0M0IIMalignant*N
I412451MBladderSquamous cell carcinoma2T2bN2M0IIIBMalignant*N
I512568MBladderSquamous cell carcinoma (inflammation)*T3aN0M0IIIAMalignant6*3.5*3N
I612667MBladderSquamous cell carcinoma2T3aN0M0IIIAMalignant4*4*3.5N
I712757MBladderSquamous cell carcinoma3T3aN0M0IIIAMalignant*N
I812852MBladderSquamous cell carcinoma3T3N0M0IIIAMalignant*N
I912976FBladderComplicated carcinoma*T2N0M0IIMalignant*N
I1013062MBladderLeiomyosarcoma*T2bN0M0IIMalignant6*2N
I1113178FBladderChronic cystitis***Inflammation*N
I1213253MBladderChronic cystitis***Inflammation*N
I1313373MBladderChronic cystitis***Inflammation*N
I1413475MBladderChronic cystitis***Inflammation*N
I1513546FBladderChronic cystitis***Inflammation*N
J113650MBladderAdenocarcinoma3T3N0M0IIIAMalignant6*5*2.5N
J213753MBladderSquamous cell carcinoma1T2N0M0IIMalignant4.5*4.5*3N
J313846MBladderSquamous cell carcinoma1T2aN0M0IIMalignant*N
J413951MBladderSquamous cell carcinoma2T2bN2M0IIIBMalignant*N
J514068MBladderSquamous cell carcinoma2T3aN0M0IIIAMalignant6*3.5*3N
J614167MBladderSquamous cell carcinoma2T3aN0M0IIIAMalignant4*4*3.5N
J714257MBladderSquamous cell carcinoma3T3aN0M0IIIAMalignant*N
J814352MBladderSquamous cell carcinoma3T3N0M0IIIAMalignant*N
J914476FBladderComplicated carcinoma*T2N0M0IIMalignant*N
J1014562MBladderLeiomyosarcoma*T2bN0M0IIMalignant6*2N
J1114678FBladderChronic cystitis***Inflammation*N
J1214753MBladderChronic cystitis***Inflammation*N
J1314873MBladderChronic cystitis***Inflammation*N
J1414975MBladderChronic cystitis***Inflammation*N
J1515046FBladderChronic cystitis***Inflammation*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情